UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 861177
NEW YORK, NY
Position in LGND
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$66,513,866
+$24,010,781 QoQ
Shares Held
210,427
-1.2% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. LGND ranks #13 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,513,866 | 210,427 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $42,503,085 | 212,888 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $68,742,822 | 363,584 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $66,711,097 | 376,601 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $44,538,569 | 391,789 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,817,078 | 55,327 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $5,400,465 | 50,401 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,987,382 | 39,838 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,864,918 | 45,869 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,150,520 | 15,739 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,124,077 | 15,739 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $943,079 | 15,739 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,344,736 | 18,651 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,371,964 | 18,651 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,177,081 | 17,621 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,517,341 | 17,621 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,572,142 | 17,621 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,446,655 | 21,750 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,165,345 | 20,493 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,989,942 | 21,461 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,886,177 | 22,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,741,353 | 17,982 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,733,609 | 17,432 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $8,394,354 | 88,065 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,097,632 | 18,754 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,363,206 | 18,746 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||